CureTech curetechbio.com


Public list: Pharma Startups (4743) Cancer Therapeutics (1146)

CureTech is a biotechnology company developing broad-spectrum, immune modulating products for the treatment and control of cancer. Building on the broad experience of its management, the company has established a well-balanced portfolio of cancer therapies with its lead humanized antibody product, CT-011, in Phase II clinical testing. CureTech's products are antibodies and peptide-based vaccines designed to modulate the immune response allowing it to exert its anti-cancer activity in an effectiv...Show all

CureTech is a biotechnology company developing broad-spectrum, immune modulating products for the treatment and control of cancer. Building on the broad experience of its management, the company has established a well-balanced portfolio of cancer the...Show all

Company (Acquired)

Phone: +972-8-932-4000

Fax:

42 Hayarkon St

Yavne, 81227
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CureTech $3.8M Mar 28, 2018
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CureTech Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pidilizumab monoclonal antibody therapy following stem cell transplantation Nov 07, 2014 Feb 28, 2017 Patent
Variants of humanized immunomodulatory monoclonal antibodies Mar 18, 2014 Aug 16, 2016 Patent
Monoclonal antibodies for tumor treatment Apr 29, 2014 Apr 12, 2016 Patent
Monoclonal antibodies for tumor treatment Feb 11, 2009 Jun 10, 2014 Patent
Variants of humanized immunomodulatory monoclonal antibodies Jul 23, 2012 Apr 01, 2014 Patent
See all 8 patents